What does this research mean for the field?

Compound 53 is a potent HPK1 inhibitor with an IC50 of 1.7 nM and demonstrates significant in vivo antitumor efficacy, making it a promising candidate for cancer immunotherapy. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aims to identify and optimize novel HPK1 inhibitors for potential cancer immunotherapy applications.

March 16, 2026Journal of Medicinal Chemistry

Discovery of Novel HPK1 Inhibitors via Chemistry-Based Direct-to-Bioassay Screening and SAR Optimization

View Full Paper

Ask AI

Bookmark

Authors

YDYiping DuanChina Pharmaceutical University CHChen HeChina Pharmaceutical University ZGZhichao GuoChina Pharmaceutical University

Discussion

Member takes

Implication

Research demonstrates HPK1 inhibition enhances IL-2 release in cancer models, suggesting its potential for immunotherapy.

Key Points

The study aims to identify and optimize novel HPK1 inhibitors for potential cancer immunotherapy applications.
Developed an in-house library of HPK1 inhibitors using combinatorial chemistry techniques.
Conducted in silico fragment recombination and molecular docking to identify lead fragments.
Assembled selected fragments into compounds for direct biological assays in a microplate format.
Performed structure-activity relationship studies to optimize the lead compounds.
Identified lead compound 8b through direct biological assays.
Optimized compound 53 exhibited an HPK1 IC50 of 1.7 nM.
Compound 53 suppressed SLP76 phosphorylation and enhanced IL-2 release in cells.
Demonstrated low CYP/hERG risk and significant antitumor efficacy in mouse models.

Cite This Study

Duan et al. (2026) studied this question.

synapsesocial.com/papers/69b79e398166e15b153ab384 https://doi.org/10.1021/acs.jmedchem.5c02998

View Full Paper

Ask AI

Bookmark

Discovery of Novel HPK1 Inhibitors via Chemistry-Based Direct-to-Bioassay Screening and SAR Optimization

Discussion

Member takes

Implication

Key Points

Cite This Study

Discovery of Novel HPK1 Inhibitors via Chemistry-Based Direct-to-Bioassay Screening and SAR Optimization

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider